Patents
US 12746280 B2: Chagas disease vaccine antigens with improved stability and decreased aggregation
- Granted
- 2026-09-29
- Filed
- 2020-10-14 application 17769113
- Type
- Utility · 14 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Provided herein are compositions and methods for the prevention and treatment of Chagas disease and acute and chronic symptoms thereof. The compositions comprise recombinant proteins based on an amino terminal fragment of the TSA-1 protein from Trypanosoma cruzi. In the fragment, one or more Cys residues is mutated to prevent the formation of disulfide bonds and to enhance solubility. The recombinant proteins also include a carboxyl terminal fragment of the TSA-1 protein from Trypanosoma cruzi to provide additional stability and solubility. The resulting recombinant protein remains soluble upon prolonged storage at low temperatures and elicits a robust immune response upon administration, including decreasing the number of inflammatory cells in heart tissue of subjects.
Source: PTBLXML, file of 2026-09-29 (ipgb20260929.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Baylor College of Medicine 276 patents | US company or organization | Houston, TX | Baylor College of Medicine College or university EXACT high confidence: identical full name and state BAYLOR COLLEGE OF MEDICINE Nonprofit EXACT high confidence: identical full name and state | PTBLXML, file of 2026-09-29 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Bin Zhan | Houston, TX | PTBLXML, file of 2026-09-29 | ||
| Peter Jay Hotez | Houston, TX | PTBLXML, file of 2026-09-29 | ||
| Maria Elena Botazzi | Houston, TX | PTBLXML, file of 2026-09-29 | ||
| Jaime Ortega-Lopez | Cuidad de Mexico, MX | PTBLXML, file of 2026-09-29 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/005 | PTBLXML, file of 2026-09-29 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P33/02 | PTBLXML, file of 2026-09-29 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
No recorded assignments or security interests on file for this patent.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.